4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-23-032655
CEO, CFO, Director bought 15,000 shares at $0.66 ($9,825)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Finley John David CEO, CFO, Director | 2023-09-13 | Purchase | +15,000 | $0.66 | $9,825 | 28,394 | D: show line 1 in the form |
| Open-market purchases · 15,000 sh · avg $0.66 · $9,825 | |||||||
Loading xslF345X05/ownership.xml…